摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 693226-09-4

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
693226-09-4
化学式
C10H15N3O4S2
mdl
——
分子量
305.379
InChiKey
MMZHCWDPQHGEHM-MRVPVSSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    536.1±60.0 °C(Predicted)
  • 密度:
    1.56±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.35
  • 重原子数:
    19.0
  • 可旋转键数:
    3.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    92.5
  • 氢给体数:
    1.0
  • 氢受体数:
    6.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-甲基吗啉potassium carbonate1-羟基苯并三唑1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下, 生成 (S)-3-(4-Dimethylcarbamoyloxy-phenyl)-2-{[(R)-5,5-dimethyl-3-(1-methyl-1H-pyrazole-4-sulfonyl)-thiazolidine-4-carbonyl]-amino}-propionic acid 2-phenoxy-ethyl ester
    参考文献:
    名称:
    Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists
    摘要:
    A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described. Potential pro-drugs were evaluated for their physical chemical characteristics and in vitro properties, including solubility, stability, permeability and plasma stability. Based on this characterization, promising compounds were identified for in vivo pharmacokinetic evaluation. These studies resulted in the identification of a pro-drug that exhibited desirable blood levels in PK studies in several different species. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2004.01.062
  • 作为产物:
    参考文献:
    名称:
    Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists
    摘要:
    A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described. Potential pro-drugs were evaluated for their physical chemical characteristics and in vitro properties, including solubility, stability, permeability and plasma stability. Based on this characterization, promising compounds were identified for in vivo pharmacokinetic evaluation. These studies resulted in the identification of a pro-drug that exhibited desirable blood levels in PK studies in several different species. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2004.01.062
点击查看最新优质反应信息